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INTRODUCTION
               Neurosurgeon Dr.  James Drake writes “Perhaps no neurosurgical 
complication is as distressing as a CSF shunt infection”.
The placement and revision of ventriculoperitoneal shunt remains a mainstay 
in the surgical treatment of hydrocephalus. Ventriculoperitoneal shunting is by far 
the most popular technique for cerebrospinal fluid (CSF) diversion. It is relatively 
simple,  suitable  for  patients  of all  ages  with hydrocephalus from any cause like 
myelomeningocele,  aqueductal  stenosis,  preceding  meningitis,  preceding 
subarachnoid haemorrhage, CNS tumour, postopertive adhesion, head trauma, other 
congenital  malformations  and  other  acquired  etiology.  Ventricular  shunts  have 
obviously changed the prognosis for individuals with hydrocephalus, and most attain 
fairly normal intelligence.
In patients who never had a VP shunt inserted before, a shunt can usually be 
inserted usually in less than an hour. It is important to try to do the procedure as 
quickly as possible to minimize the risk of infection.
Infection  is  unfortunately  a  relatively  frequent  complication  of  shunt 
placement, which contributes significantly to excess morbidity and mortality. Shunt 
infections put the patient at increased risk of intellectual impairment, development 
of loculated CSF compartments, and even death. In several large studies since 1971, 
the  case  incidence  of  shunt  infection  has  ranged  from 8-40% and the  operative 
incidence has ranged from 2.8-14%.10
Four mechanisms may be postulated by which shunts become infected: 
a) colonization at the time of surgery being the most frequent cause
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 b) retrograde infection from the distal end,
  c) wound or skin breakdown 
d) hematogenous  seeding  which  is  a  possible  occurrence  but  not  a 
frequent one.
Most infections present in early postoperative period which suggests that the 
perioperative contamination from the patient's skin may be an etiologic mechanism. 
Of  all  the  factors  that  have  been  reported  to  predict  an  increased  risk  of  shunt 
infection  (time  of  surgery,  etiology  of  hydrocephalus,  use  of  prophylactic 
antibiotics, number of revisions, site of shunt placement, type of revision, age of 
patient,  surgeon),  only  poor  skin  condition  and  age  of  the  patient  are  clear 
predisposing factors.
The  presentation  of  shunt  infection  can  be  quite  variable.  The  signs  and 
symptoms  of  shunt  infection  are  fever,  seizures,  symptoms  related  to  shunt 
malfunction such as headache, vomiting, change in mental status, wound infections 
and cellulitis along the shunt.
The most frequently isolated microorganisms are of Staphylococcus species 
including  Staphylococcus epidermidis and  Staphylococcus  aureus. Furthermore 
increases  in  polymicrobial,  Gram-negative  bacilli  infections  (Escherichia  coli,  
Klebsiella  species,  and  Pseudomonas  species)  are  observed  now-a-days.  The 
remainder are due to  Streptococcus  species, Enterococcus  species, anaerobes  and 
yeasts.
DEFINITION OF SHUNT INFECTION
Shunt  infection  can  be  defined  as  isolation  of  the  organism  from  the 
ventricular  fluid  or  shunt  hardware  along  with  clinical  signs  and  symptoms 
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suggestive of shunt infection or malfunction like fever, peritonitis, meningitis, signs 
of infection along the shunt tract, or nonspecific signs and symptoms of headache, 
vomiting, change in mental status, or seizures.
A combination of clinical suspicion and laboratory testing, primary analysis 
of the CSF aid in the identification of shunt infection. Positive culture results from 
either the CSF or shunt apparatus provide a reasonable working diagnosis for shunt 
infection. 
The value of prophylactic antibiotic administration in the prevention of shunt 
infection remains unproved.
Like prevention of shunt infection, treatment of shunt infection is equally 
challenging. Four treatments of shunt infection have evolved:
1. Medical (antibiotic) treatment,
        2. Shunt removal with delayed replacement,
        3. Shunt removal with immediate replacement,
4. Externalization  of  the  shunt  or  installation  of  external  ventricular 
ventricular drainage (EVD) along with antibiotics, which is the most 
effective treatment.
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AIM OF THE STUDY
 To find out the infection rate associated with ventriculoperitoneal shunts.
 To  study  the  association  between  the  underlying  conditions  that 
necessitate shunt and the development shunt infection.
 To evaluate the risk factors associated with shunt infection.
 To isolate and identify the causative pathogens.
 To  evaluate  the  usefulness  of  CSF  Gram  staining,  cell  count  and 
biochemical parameters to identify infections at an early stage.
 To determine the antimicrobial susceptibility pattern of the isolates so as 
to use appropriate antibiotics.
 To study the therapeutic outcomes.
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REVIEW OF LITERATURE
                     
The use of ventriculoperitoneal shunts to treat hydrocephalus in both children 
and  adults  has  made  hydrocephalus  one  of  the  most  treatable  neurological 
conditions.  Shunting  is  the  commonest  surgical  procedure  in  a  paediatric 
neurosurgical practice. There are a few conditions treated by neurosurgeons that are 
at once so gratifying and so frustrating as hydrocephalus. Likewise, there are few 
operations  performed  by  neurosurgeons  that  are  at  once  so  simple  and  so 
unforgiving as cerebrospinal fluid (CSF) shunt insertion.
HISTORICAL BACKGROUND
The existence of CSF was known to the author of Edwin Smith papyrus in 
the 18th century B.C., and hydrocephalus was recognized by Hippocrates. Magendie 
gave a name to CSF in 1825.In 1875,Key and Retzius worked out its circulatory 
pathways.46 Modern notions of the secretion and absorption of CSF were developed 
by Weed in the first part of this century, while Dandy and Blackfan deserve credit 
for defining the concepts of the pathophysiology of hydrocephalus that led to the 
first successful treatments.68
Review of the medical measures that have been employed in the treatment of 
hydrocephalus  places  the evolution of  modern  surgical  practices  in  a  favourable 
perspective. Before the era of scientific medicine, hydrocephalus was treated by the 
usual  armamentarium  of  uncritically  selected  and  totally  ineffective  measures: 
venesection, cupping, leeching purgatives, diuretics, and so on.19
From our vantage point at the end of the twentieth century, it is clear that 
many surgeons who attacked the problem of hydrocephalus at the beginning of the 
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century had the right idea: CSF must be diverted to a body cavity where it can be 
absorbed at low pressure. Apparently the first CSF shunt was a “nail” of glass wool 
communicating  the  lateral  ventricle  with  the  subgaleal  space.19 Tubes  fabricated 
from platinum, gold, silver, glass, and rubber as well as linen threads, coiled silver 
wires,  and  strips  of  omentum  were  used  by  various  surgeons  as  drains  into 
subgaleal,  subdural,  and subarachnoid spaces. Diversion of CSF directly into the 
peritoneum was attempted as early as 1898 and there were early attempts to utilize 
the pleural space and vascular tree as receptacles for CSF as well.46
Also in 1908, the first ventriculoperitoneal shunt was inserted by Kaush, who 
used a rubber tube to connect the lateral ventricle with the peritoneal surface. The 
1950s  marked  the  introduction  of  extracranial  ventricular  shunting,  first  to  the 
vascular system and subsequently to the peritoneal cavity. The widespread use of 
ventricular shunting was made possible following the introduction of unidirectional 
valve systems and biologically inert silicone elastomer tubing. The initial ball valve 
used by Nulsen and Spitz was primitive and ineffective. A better “slit” valve was 
developed by Holter in the mid-1950s. Holter’s slit valve became one of the most 
widely used shunt valves throughout the world. Working at about the same time as 
Holter  but  unaware  of  his  work,  Pudenz  of  Padenza,  California,  developed  an 
effective unidirectional  valve that  was tested rigorously in  an animal  model  and 
implanted successfully in patients.68
Before  ventriculoperitoneal  shunting  had  achieved  widespread  use,  there 
were reports of techniques to shunt CSF from the cerebral ventricles or subarachnoid 
space to almost every body cavity. The distal shunt catheter has been placed in body 
cavities such as the subgaleal space, salivary duct, mastoid process, orbit, stomach, 
intestine, thoracic duct, gallbladder, kidney, ureter, and even the fallopian tube. The 
high  complication  rate  for  ventriculovascular  shunts  and  their  requirement  for 
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frequent  revision  led  ultimately  to  the  development  of  the  ventriculoperitoneal 
shunt,  which  remains  the  surgical  standard  for  the  treatment  of  hydrocephalus 
today.68
HYDROCEPHALUS
Hydrocephalus  is  a  clinical  state  in  which  disruption  in  normal  CSF 
dynamics occurs. The disruption may be in production, absorption, or mechanical 
obstruction  to  the  flow  of  CSF  and  is  usually  associated  with  an  increase  of 
ventricular size. The changes in CSF dynamics may be caused by congenital brain 
malformations or by many disease processes occurring with in the ventricle,  the 
brain parenchyma, or the subarachnoid spaces.
The causes of hydrocephalus are many:
In utero causes of hydrocephalus include aqueductal stenosis, spina bifida 
(Chiari  malformation,  myelomeningocele),  and  Dandy-Walker  malformation. 
Encephaloceles, holoprosencephaly, intracranial hemorrhage or cerebral infarction, 
porencephalic  cyst,  vein  of  Galen  aneurysms,  congenital  tumours  (teratomas, 
ependymomas, and astrocytomas), infection, agenesis of the corpus callosum, and 
septo- optic dysplasia.
Major  non-CNS associations  include  trisomy 13  and  18,  achondroplasia, 
pulmonary  and  renal  hypoplasia,  transposition  of  the  great  vessels,  endocardial 
cushion  defects,  hydronephrosis,  esophageal  atresia,  omphalocele,  and  intestinal 
malrotation. Post hemorrhagic hydrocephalus is common in premature neonates.
Causes  of  childhood hydrocephalus  include  mainly congenital  aqueductal 
stenosis  and  primary  CNS  tumours  like  astrocytomas,  medulloblastomas, 
gangliogliomas,  craniopharyngiomas,  and  ependymomas.  Other  causes  include 
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bacterial meningitis, trauma, and other congenital abnormalities.
Acquired  hydrocephalus  in  adults  has  many  causes.  Tumour  related 
hydrocephalus is most common with posterior fossa tumours, suprasellar tumours, 
and third ventricle and pineal region tumours. Vascular causes include Galen vein 
arteriovenous  malformations,  giant  midline  aneurysms,  and  subarachnoid 
hemorrhages.
In  a  representative  series  of  107 children,  the  causes  for  hydrocephalus  
were  myelomeningocele  (54%),  idiopathic  (13%),  posthemorrhagic  (13%), 
postmeningitic  (10%),  aqueductal  stenosis  (7.5%),  hydranencephaly  (0.1%)  and 
congenital toxoplasmosis (0.1%).1
DIAGNOSIS AND CLINICAL FEATURES
The identification of hydrocephalus begins with the clinical suspicion based 
on history and physical examination. In infants the signs include enlarging head size, 
split  cranial  sutures,  sunset  appearance,  inability  to  gaze  upward,  papillary 
abnormalities,  convergence  abnormalities,  and  nystagmus,  and  scalp  vein 
enlargement, nuchal rigidity. In children with chronic hydrocephalus, the complaints 
are more likely to relate to poor school performance and a decreased energy level.1
Imaging  techniques  often  determine  the  etiology  and  the  extent  of 
hydrocephalus.  Computerized  tomography  (CT)  is  the  commonest  imaging 
procedure used to detect hydrocephalus. Ventricular size can be identified with CT, 
as can causative intracranial lesions. Magnetic resonance imaging (MRI) has added 
to the accuracy of diagnosis in hydrocephalus, identifying sites of obstruction as 
well as small lesions not seen on CT.
VENTRICULOPERITONEAL SHUNT PROCEDURE
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Two body cavities must be entered during the procedure, the ventricle and 
the peritoneum. The ventricular catheter is usually placed in the anterior horn of the 
lateral ventricle, as close to the foramen of Monro as possible. The site of entry of 
the distal peritoneal catheter into the peritoneal cavity is as high on the abdomen as 
possible  (shortest  distance  possible  from ventricle  to  peritoneum),  subxiphoid or 
subcostal usually just over the liver are the most commonly used approaches for 
exposure of the peritoneum during VP shunt insertion.
The ventricular catheter, valve and peritoneal tubing are all foreign bodies 
that can harbor bacteria introduced by contamination at the time of surgery or by 
seeding of organisms introduced into the bloodstream by a variety of surgical and 
non-surgical mechanisms unrelated to the VP shunt insertion procedure.
A subcutaneous tunnel is made from the scalp to the abdominal incision by 
use of a blunt salmon passer.  The tunnel is created by pushing a hollow metal tube 
down through the soft tissues under the skin above the fascia of the neck and chest 
muscles. The distal catheter is passed through the subcutaneous tunnel. A special 
instrument  set  has  been  recently  designed  to  assemble  shunts  with  “no-touch” 
technique.
The  dura  is  then  opened  with  a  crucial  incision.  Using  the  landmarks 
mentioned earlier, the ventricle is cannulated with the proximal catheter on a stylet. 
The stylet is withdrawn as soon as the ventricle is entered, and the catheter is pushed 
in  about  1cm more  than  the distance  of  the parietal  burr  hole  from the  coronal 
suture.
     The CSF specimen is obtained from the distal  catheter,  and good flow is 
confirmed. At this stage, the posterior rectus sheath is opened, the peritoneum is 
identified,  and  the  distal  catheter  is  placed  intraperitoneally  under  direct  vision. 
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About 90-120 cm of tubing is left in the abdomen, which may be sufficient for life 
in some patients. The anterior rectus sheath is closed with absorbable suture, and 
subcuticular abdominal sutures are placed for good cosmesis. The scalp wound is 
closed with absorbable galeal sutures and running nylon on the skin.
SHUNT REVISION
Revision (reoperation for removal or adjustment of one or all components of 
VP shunt system) is one of the most common procedures done by neurosurgeons.
Recovery:  The  abdominal  and  scalp  incisions  heal  within  seven  days. 
Patients can return to work with in two weeks of shunt insertion.
INDICATIONS  AND  CONTRAINDICATIONS  FOR  CSF  SHUNT 
INSERTION
Generally hydrocephalus should be treated if it is progressive, even if it is 
asymptomatic, and it should be treated if it is symptomatic, even if the symptoms are 
subtle or atypical.
Indications of shunt treatment can be brought into focus by examining the 
contraindications which include: Ventriculitis, other inadequately treated infections, 
acute  intraventricular  haemorrhage,  hydrocephalus  due  to  treatable  obstructive 
lesions  futility  on  the  basis  of  extreme  brain  pathology (i.e.,  hydranencephaly), 
asymptomatic,  nonprogressive  hydrocephalus  and  ventriculomegaly  without 
elevated intracranial pressure.
SHUNT COMPLICATIONS
Following ventricular shunting a wide variety of complications occur, which 
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include:  i)  Infections,  and  wound  complications,  ii)  Proximal  and  distal  shunt 
obstruction  leading  to  shunt  malfunction,  iii)  Seizures,  iv)  Extra  cerebral  fluid 
collections,  v)  Subdural  hematomas,  vi)  Spontaneous  pnemocephalus,  vii)  The 
overdrainage syndrome, viii) Ascites,  ix) Bowel perforation, x) The slit ventricular 
syndrome.
EPIDEMIOLOGY 
Infection  is  unfortunately  a  relatively  frequent  complication  of  shunt 
placement, with most authorities quoting a figure of approximately 7 to 10 percent 
per procedure, which contribute significantly to excess morbidity and mortality.74
While the North American infection rate averages nearly 8-10%, published 
infection rates for VP shunt infection below 1% have been reported.69 Postoperative 
infections of CSF shunt infections occur in 5-27% of cases in most neurosurgical 
units throughout the world.51, 85
In a review 612 procedures performed on 306 patients, infection occurred 
following 46 of the procedures with an infection rate of 7.5 per procedure involving 
39 patients. The infection rate per child was 12.7%.24
From 1986 to 1989 273 ventriculoperitoneal shunts were performed, out of 
which twenty eight infectious episodes (8%) occurred in 25 patients during a median 
follow-up time of 20 months.49
An  infection  rate  of  4%  occurred  in  a  study  done  in  Department  of 
neurosurgery, Indianapolis from 1980-1983 involving about 505 operations.82
PATHOGENESIS 
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Four mechanisms10 have been postulated by which shunts become infected. 
a) colonization at the time of surgery,
b) retrograde infection from the distal end,
c) wound or skin breakdown 
d) hematogenous  seeding  which  is  a  possible  occurrence  but  not  a 
frequent one.
Colonisation at the time of surgery is probably the most frequent cause of 
shunt  infections.  This  is  suggested  in  particular  by  the  timing  of  most  shunt 
infections and by the organisms isolated from these infections. At operation, direct 
exposure and handling of the shunt can allow bacterial contamination.
Most shunt infections occur with in 2 months of shunt insertion. 80% will 
present with in three months and 90% within six months.33
Clustering  of  approximately  70%  of  infections  within  2  months 
postoperative  period  suggests  that  colonisation  during  shunt  placement  is  an 
important initiating event.31
Most often the infection results  from colonization of the shunt device by 
normally nonpathogenic normal skin flora at the time of surgery.6, 82
Retrograde  infection  includes  infection  of  the  distal  end  by  transluminal 
passage of  bacteria  without  perforation,  delayed perforation of  the bowel  by the 
distal  catheter.  It  is  the  most  likely  mechanism  involving  infection  of  the 
externalized devices. Organisms may track from the exit site alongside the device or, 
in case of devices that drain CSF, gain entry into fluid column and ascend into CNS.
Breakdown of the surgical wounds or the skin overlying the shunt hardware 
allows direct access of microbes to the shunt. This may be surgically acquired, when 
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the incision fails to heal for intrinsic causes like malnutrition, improper closure or 
because an impaired patient picks at or scratches open the wound. Direct extension 
from adjacent infected tissues like tracheostomy wounds, an intravenous access site, 
severe skin infections like acne, boils, cellulitis.53
In a prospective study by Duhaime et al.21 on distribution of bacteria in the 
operating room environment and its relation to ventricular shunt infections, bacteria 
most  often  associated  with  shunt  infections  are  airborne  in  the  operating  room, 
rather than originating from the patient’s  skin,  and are distributed in  the highest 
concentration near the surgical team.
The mere presence of a foreign body can markedly increase the pathogenic 
potential of an organism of otherwise low virulence.30,54 The foreign material can 
directly  interfere  with  natural  host  defense  mechanisms,  such  as  chemotaxis, 
phagocytosis, or the inflammatory process.88,98
MECHANISM OF SHUNT COLONISATION
• Attachment  of  bacteria  to  the  shunt  is  the  initial  step  in  colonization  and 
infection.   
• Implanted  shunt  is  almost  immediately  coated  with  glycoproteinaceous  film, 
which is derived from serum and extracellular matrix proteins.34
• This provides potential receptor sites for bacterial or tissue adhesion.
• If tissue cells are the first to adhere to and integerate within the shunt surface, 
then the surface resists bacterial colonisation.
• Bacterial adhesion and multiplication produces a biofilm on the surface of the 
shunt  which  will  eventually  produce  a  clinical  shunt  infection.  This  biofilm 
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reduces the penetration of antibiotics and prevents elimination of bacteria, with 
antibiotic treatment alone.  S. epidermidis produces an extracellular glycocalyx 
slime  (composed  mainly  of  a  mixture  of  polysaccharides  and  proteins)  and 
therefore bind well to a shunt and may account for their likelihood in presenting 
with true shunt infection.10
Bacterial adherence to cerebrospinal fluid (CSF) shunts was analyzed in vivo 
and  in  vitro.  Scanning electron  micrographs  (SEM's)  of  catheters  removed from 
pediatric  patients  with  shunts  infected  by  Staphylococcus  aureus or  Klebsiella  
pneumoniae revealed numerous bacterial cells and microcolonies, leukocytes, and 
erythrocytes attached to the CSF catheters' inner walls, as well as the existence of 
surface irregularities, such as fissures, rugosities, and holes. Permeability analyses 
and SEM's demonstrated that catheters develop physical alterations over the period 
of implantation. Different bacterial strains presented a different in vitro adherence to 
CSF shunts, suggesting that this attachment may be affected by specific properties 
of the outer structures of each strain.37
The attachment of microbial pathogens to CSF shunts seems to contribute to 
the persistence of bacterial cells within a catheter and the onset of recurrent shunt 
infection. This study demonstrated that some bacteria can remain attached within 
shunts  in  vitro despite  a  CSF  flow  at  rates  up  to  200  times  higher  than  those 
normally demonstrated in vivo. Furthermore, surface irregularities found throughout 
this  study may help  to  anchor  and hide bacterial  microcolonies.  Based on these 
findings, it seems advisable to remove an infected shunt and to replace it with a new 
one after proper antimicrobial therapy, in order to prevent recurrent infections.37
There is recent evidence to suggest that the adherence capacity of Klebsiella  
pneumoniae strains  to  CSF  shunts  and  other  smooth  surfaces  is  genetically 
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correlated  with  the  presence  of  some  deoxyribonucleic  acid  (DNA)  extra 
chromosomal elements. Abdominal complications and associated shunt infections 
suggested two potential modes of development: (1) descent of contaminated CSF 
from an infected shunt into the abdomen and the bacteria were predominantly Gram-
positive, cutaneous microorganisms and (2) ascent of bacteria into the shunt from an 
abdominal  source  and  the  bacteria  were  mixed,  Gram-negative  intestinal 
microorganism.77 
The most frequently isolated microorganisms are of Staphylococcus species 
including  Staphylococcus epidermidis  and Staphylococcus  aureus.  Furthermore 
increases  in  polymicrobial,  Gram-negative  bacilli  infections  (Escherichia  coli,  
Klebsiella species,  and  Pseudomonas species)  are  observed  now-a-days.  The 
remainder  are  due  to  Streptococcus  species,  Enterococcus  species, anaerobes, 
yeast.9, 10, 51, 73, and 87
Organisms responsible for shunt infections in children have been consistent 
over time and from series to series.  Staphylococcus epidermidis is the commonest, 
and more than 40 percent of the positive cultures with  Staphylococcus aureus are 
approximately 20 percent. Gram-negative organisms are the next commonest group, 
with  Escherichia  sp., Klebsiella  sp.,  and  Pseudomonas  sp. being  the  organisms 
specified.  Various  other  Gram-positive  organisms,  such  as  Corynebacterium, 
Streptococcus  faecalis,  Micrococcus,  H.  influenzae,  and  Propionibacterium also 
appear. Multiple organisms were presenting 30.5% of shunt infections in Odio and 
colleagues’  series  but  in  only  10% in  Schoenbaum and  colleagues’  series.  The 
source of organisms remains unclear; only 20% in one series were identical to skin 
organisms in those patients, suggesting that perioperative contamination from skin 
may not be the only etiologic mechanism.1
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In a review of 35 CSF shunt infections in 32 patients , causative organisms 
included  Staphylococcus  epidermidis in  twenty  one,  Staphylococcus  aureus in 
seven, Gram-negative aerobic bacilli in seven,  diphtheroids in five,  Streptococcus 
species in four and anaerobes in three.28 
In  a  review  on  Gram-negative  bacilli  (GNB)  shunt  infections  treated  at 
Children’s Memorial Hospital from January 1986 to January 1990, Escherichia was 
isolated in 52% of cases,  Klebsiella pneumonia from 22% and mixed GNB from 
13% of cases.86
Morbidity and mortality rate are high in Gram-negative infections.24, 81
Clinical  significance  of  slime  production  in  ventriculoperitoneal  shunt 
infections caused by Coagulase- negative staphylococci
 Coagulase-negative Staphylococci (CNST) are the most-common cause of 
ventriculoperitoneal  shunt  infections.  Some of  these  strains  produce  a  slime-like 
substance. In a review of 19 episodes of ventriculoperitoneal shunt infections due to 
CNST in 17 patients, eleven episodes of infection were caused by slime-producing 
CNST and eight by non-slime-producing CNST. Shunt obstruction and abdominal 
pain  occurred  more  frequently  when  infectious  episodes  were  due  to  slime-
producing  CNST  than  to  non-slime-producing  CNST.  Despite  appropriate 
antimicrobial  therapy,  the  mean  duration  of  fever  was  longer  and  the  failure  to 
eradicate the infecting organisms was more frequent when the infectious episodes 
were due to slime-producing CNST than to non-slime-producing CNST.20
RISK FACTORS 
The  various  risk  factors  of  shunt  infection  as  described  by  Stephen  J. 
Haines87 are
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1. Young age33, 72, 74
2. Infection, disruption or poor condition of patient.25
3. concomitant systemic infection at time of shunting15
4. Postoperative wound dehiscence61, 74
5. Prolonged operating time27
6. Cause of hydrocephalus (Myelomeningocele > others) 40, 48, 56
7. Limited surgeon experience with cerebrospinal shunts89
8.  Shunt revision (versus initial shunt) 92
9.   Shunt surgery done late in day33, 74
10. Increased number of people in operating room38
11. Ventricular catheter revision74
Meirovitch  et  al.58 had  quoted  in  their  work  on  CSF shunt  infections  in 
children that age younger than 3 years, previously infected  shunt ,surgery to revise 
the infected shunt,  patients  with multiple revision,  underlying myelomeningocele 
and meningitis have a greater risk of infection than others.
Shunt  infections  may  also  be  related  to  transient  bacteremias,  lowered 
immunologic  competence  of  that  particular  patient  and  other  poorly  understood 
factors.46 
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Statistically significant relationships were found between shunt infection and 
the following factors:
1. Age infection was as 2.6 times more frequent before 6 months than 
after 1 year of age.
2. poor condition of the skin.
3. type of operation: the rate of infection was 8.4% in primary shunt 
insertions, 5% in shunt revisions, and 17.5% in reinsertions following 
shunt removal for infection.74
4. end of shunt requiring revision: an infection rate of 7.7% followed 
revision of the ventricular catheter alone, and 2.6% followed revision 
of the other end alone and74
5. postoperative wound dehiscence or scalp necrosis.74
Young age (less than 6 months) seems to represent the main risk factor, and 
this is related both to the immunologic deficiency and to the particular features of 
residential bacterial flora in this group. Increased risk of Gram-negative infections 
also exists in this population.18
In  a  study,  done  in  division  of  Neurosurgery  in  University  of  Toronto, 
Canada, the authors prospectively analyzed perioperative risk factors for CSF shunt 
infection  in  a  cohort  of  children.  Between 1996 and 1999,  299 eligible  patients 
underwent CSF shunt operations (insertions and revisions) that were observed by a 
research nurse at a tertiary care pediatric hospital. Several perioperative variables 
were recorded. All cases were followed postoperatively for 6 months to note any 
development of CSF shunt infection. Thirty-one patients (10.4%) experienced shunt 
infection.  Three  perioperative  variables  were  significantly  associated  with  an 
increased  risk  of  shunt  infection:  1)  the  presence  of  a  postoperative  CSF leak;  
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2) patient prematurity (< 40 weeks' gestation at the time of shunt surgery), and 3) the 
number of times the shunt system was inadvertently exposed to breached surgical 
gloves.50
A trend showing a higher risk for shunt infections operation time was noticed 
in a study with an infection rate of 13.6% for an operation lasting more than 90 
minutes and 5.2% for procedures of less than 30 minutes duration.49
CLINICL FEATURES
Clinical manifestations of shunt infections are often non specific and fever is 
the only consistent finding. Therefore a high index of suspicion and low threshold 
for diagnostic evaluation are indicated.31 In many cases usual physical findings of 
meningitis may be absent with low grade temperature, shunt malfunction, wound 
infection as the only finding.
Shunt malfunction is being the least recognized symptom of shunt infection 
and studies show that  shunt malfunction may be more specific  to  infection than 
heretofore believed. The symptoms of shunt malfunction are the same as seen with 
the  initial  hydrocephalus,  with  additional  shunt  specific  findings  such  as  fluid 
around the shunt, abdominal pain, or distention and symptoms referable to infection 
may  be  seen.  In  addition  23-65%  percent  shunt  infections  present  as  shunt 
malfunction.93
Shunt infection is suspected when there is unexplained fever in a shunted 
patient. Fever is present in 50% of shunt infections. There may be concomitant signs 
of shunt malfunction if obstruction occurs secondary to occlusion of a ventricular 
catheter  or  valve  with  infected  material  or  to  the  development  of  peritoneal 
loculations. Non specific symptoms of raised intracranial pressure include headache, 
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nausea, vomiting, altered intellectual performance, seizures, ataxia and altered level 
of consciousness.52 
In a retrospective review of 68 shunt infections in 61 children in Cardinal 
Glennon,  Children’s  Hospital,  USA94 the  presenting  symptoms  included  fever 
(26%),  abdominal  pain  (19%),  wound  changes  (22%),  and  indicators  of  shunt 
malfunction (33%).
SIGNS
Bulging anterior fontanelle, raised blood pressure, bradycardia, paralysis of 
upward  gaze,  meningismus  occurs  in  15-25%.  Wound  may  have  cellulitis  or 
dehiscence. There may be local signs of infection such as redness along the shunt 
tract or tender subcutaneous collections along or adjacent to the tubing. Peritoneal 
signs include abdominal tenderness with or without guarding, encystment of catheter 
with a palpable abdominal mass, or decreased absorption with ascites. Bacteremia is 
unusual unless the distal end is placed in venous space.52
DIAGNOSIS
Shunt  infections  are  not  uncommon  and  they  are  highly  variable  in 
presentation.  Therefore,  an important attitude in dealing with shunts is to have a 
high degree of suspicion for infection. In all cases, the correlation of the clinical 
situation, symptoms, laboratory findings, and cultures must be made to diagnose a 
shunt infection.
There  are  several  diagnostic  tests  that  may be  obtained  in  an  attempt  to 
define a shunt infection.  Blood counts,  abdominal ultrasounds,  and computerized 
tomographic  (CT)  scans  of  the  head  and  abdomen  are  non-specific  that  would 
indirectly indicate infection.
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BLOOD
i) Complete Blood Count-  Where as one-third of patients  with shunt 
infections exhibit a WBC count greater than 20,000 up to one-quarter 
will have no elevation in the count.28, 80
ii) Culture:  When  VP  shunts  are  infected  blood  cultures  are  almost 
always  negative,  presumably  due  to  lack  of  direct  access  of 
organisms to the blood stream.50
CT SCANS
Computerised tomography (CT) scans of head or abdomen show evidence of 
shunt dysfunction, an indirect indication of some infections.
X-ray shunt series may detect breaks or links in shunt tubing.
ULTRASOUND
Ultrasound abdomen can identify CSF loculations.
CSF ANALYSIS
CSF is sent for i) Biochemical analysis 
(glucose and protein, Pandy's test for globulin)
                                            ii) Cell counts - Total and differential counts
iii) Gram stain
                                          iv) Culture.
A high WBC count in the CSF is  highly correlated with the presence of 
infection but infection may still be present in spite of normal counts.64, 80
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CSF protein and glucose often normal.50
Gram stain may reveal organisms but a negative Gram stain similarly does 
not exclude an infection with any degree of certainity.95
Once the suspicion of shunt infection is raised, the diagnosis must be made 
by sampling the CSF or the shunt apparatus.
Direct culturing of the shunt or any fluid in contact with it is the most accurate 
diagnostic test for infection.28, 30, 64, 66
The definitive diagnosis is made by recovery of the organisms in culture. 
WOUND CULTURE: In 18-23% of shunt infections associated with wound 
infections, the diagnosis is made easy.
IMMULOCGIC EVALUATIONS
Evaluation  of  antibody  titres  to  S.  epidermidis,  raised  C-reactive  protein 
levels and depressed complement levels can be used to confirm the diagnosis  of 
shunt infection.5
MANAGEMENT
PREVENTION OF CSF SHUNT INFECTIONS
Given the significant cost, morbidity, and the occasional mortality associated 
with  these  infections  and  their  treatment,  effective  treatment  would  be  highly 
beneficial.
Alterations  in  the  hardware,  changes  in  operating  techniques,  as  well  as 
prophylactic use of antibiotics have been suggested.
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Incorporation of antibiotics into the polymers used in shunt hardware has 
been attempted.4, 6  The goal is for a relatively slow release of antibiotics from the 
compound during early postoperative period, thus preventing the establishment of 
infection.
Attention to operative techniques used during shunt surgery can also result in 
a decline in the rate of infection, either by reducing the potential for inoculating 
organisms or by reducing the size of the inoculum. Methods of skin preparation that 
reduce the total number of bacteria and that maintain that reduction (i.e., long acting 
iodinated  compounds)  would  accomplish  this.6,47   Exclusion  of  skin  from  the 
operative field may have the same effect. 
The  results  from  the  large  number  of  studies  on  prophylactic  use  of 
antibiotics are less clear.
Some studies reveal a three-to-five-fold reduction in infection with the use of 
prophylactic antibiotics.11, 35,  96
Others  have  interpreted  from  their  results  that  there  is  no  benefit  from 
antibiotic prophylaxis.38, 79
Meta  analysis  has  been  applied  to  the  various  studies  of  prophylactic 
antibiotic usage in shunt surgery.
It appears that prophylactic antibiotic use does reduce the risk of infection in 
shunt surgery. The greatest risk reduction occurs in those groups with a relatively 
high baseline rate of infection, perhaps>12%. A much smaller benefit is still likely 
at low rates of infection (5%).39
TREATMENT OF CSF SHUNT INFECTIONS
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Three main goals in the treatment of any CNS prosthetic device infection 
are: a) minimizing the mortality and morbidity of the infection and its treatment;  
b) maintaining a functioning device if it is still needed; c) resolving the infection.
The different treatment modalities of shunt infection are:
1) Medical (antibiotic) treatment alone.
2) Shunt removal with immediate replacement.
3) Shunt removal with delayed replacement.
Externalization of the shunt (or installation of external ventricular drainage 
(EVD) with antibiotic therapy.
Medical Therapy Alone
Early in the experience of paediatric neurosurgeons, a CSF shunt infection 
was treated  only with antibiotics,  such  as  those for  any systemic  infection.  The 
combination  of  poor  antibiotic  penetration,  development  of  secondary  bacterial 
resistance and bacterial colonization of the shunt material can result in high failure 
rate, followed by relapse. Such treatment is usually reserved for circumstances in 
which  the  clinician  is  unsure  of  the  diagnosis  and  in  which  the  shunt  is  still 
functioning.
Drugs  very  effective  are  vancomycin,  nafficillin,  rifampin,  oxacillin, 
linezolid  in  case  Gram  positive  organisms  where  as  aminoglycosides, 
cephalosporins,  polymixin  B,  meropemam  are  found  effective  against  Gram-
negative organisms.29, 36, 45
In  case of  fungal  infections  any of  the  antifungals  like  amphotericin  B,  
5-flurocytosine, miconazole and fluconazole can be used.10
30
Shunt Removal with Immediate Replacement
Combining  the  removal  of  presumably  colonized  shunt  hardware  with 
immediate shunt placement might be expected to cause an improvement in the rate 
of successful treatment. This would remove the densely adherent bacteria that are 
otherwise protected from the antibiotic by their glycocalyx or slime. It would also 
allow the continued control of the hydrocephalus. Infact, when parenteral antibiotics 
are combined with this approach, roughly 75% of the infection can be cured.10,89
The  failure  and  reinfection  rates  still  remain  quite  significant  with  this 
technique. In addition there is possibility that the replaced hardware may become 
colonized by the bacteria under treatment48
Shunt removal with delayed placement
When possible, the treatment of CSF shunt infections is complete removal, 
aggressive treatment with antibiotics, and placement of a new shunt after the CSF is 
completely  negative  on  cultures  for  microorganisms.  Delayed  replacement  does 
seem to improve the cure rate but it may also be associated with increased morbidity 
and mortality.28, 93
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External Ventricular Drainage with antibiotic therapy
The final category of treatment  is  the procedure most  commonly used in 
cases of shunt infection and appears to be the most effective treatment.43,67,  80  It 
consisted of placing a sterile EVD system and removing the infected shunt, treating 
the  patient  with  systemic  (with  or  without  intraventricular)  antibiotics,  and  then 
removing the EVD and placing a new shunt. This method of treatment is probably 
the soundest in terms of removing the infected foreign body while continuing to 
treat the hydrocephalus and avoids the complications that might ensue with only 
shunt removal.44, 45
The most significant risk with external shunts is that of secondary infection.10
CSF SHUNTS – RESULTS
The simplest outcomes to analyze are patient survival and shunt survival.
Mortality rates from shunt infection have been reported as high as 35%, but 
rates from recent years are much lower.46
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MATERIALS AND METHODS
This is a cross sectional study done involving 428 patients which included 
404 patients who underwent primary ventriculoperitoneal shunt insertions during the 
study period  and  also  24  old  cases  of  shunt  insertion  who  underwent  revision. 
During the study period 120 cases of malfunction occurred.
Place of study 
Institute  of  Microbiology,  and  Department  of  Neurosurgery, 
Madras Medical College.
Period of study
MAY 2004 - OCTOBER 2005.
Study Group
120 patients both male and female of age group ranging from 0-60 were 
chosen.  Patients with hydrocephalus of various etiology who had already undergone 
shunt surgery now presenting with signs and symptoms suggestive of shunt infection 
such  as  fever,  seizures,  headache,  disturbed  consciousness,  vomiting,  abdominal 
signs and other signs of shunt malfunction now undergoing shunt removal or shunt 
revision without removal of the shunt were studied.
Two groups were studied:
GROUP 1: This included 96 patients with shunt malfunction for whom 
shunt insertions were done during the study period. i.e. from 
404 cases.
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GROUP 2: This included 24 patients with shunt malfunction for whom 
shunt insertions and revisions were already done before the 
study period.
Data regarding patients were collected as per mentioned in the proforma.
COLLECTION AND TRANSPORT OF SPECIMENS
The samples collected were
1. CSF 
2. CSF Shunt (Catheter) tip.
3. Blood.
4. Wound swab in cases of associated wound infection.
5. Swabs from the nose, ear, and skin around umbilicus.
6. Swabs from the environment- in the neurosurgery operation theatre 
as well as from the neurosurgical ward.
CSF AND CSF SHUNT TIP 
1. CSF was obtained during surgery or by means of lumbar puncture or from 
the  reservoir  site  like  the  external  ventricular  drainage,  following  sterile 
precautions.
2. CSF Shunt tip was obtained during surgery.
CSF and CSF shunt tip were collected in a sterile screw-capped containers.
Three separate tubes of CSF fluid were collected- 
i) Tube 1 for cell counts - Total and differential counts.
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ii) Tube 2 for Gram stain and culture.
iii) Tube 3 for biochemical analysis  like protein,  glucose and Pandy’s 
test for globulin. 
CSF was hand-delivered immediately to the laboratory. Specimens was not 
be refrigerated. If not rapidly processed, CSF was incubated at 37ºC or left at room 
temperature.
BLOOD17 
Patient blood was obtained by aseptic venipuncture. In case of adults, about 
10-20 ml was collected. In case of infants and children only 1-5 ml was collected. 
Blood was directly inoculated into Brain - Heart Infusion broth, in a ratio of about 
1:5 to dilute any inherent antibiotics or other antibacterial substances.
WOUND SWABS
Two swabs with adequate material, taken from the depth of the wound, were 
collected-one for Gram staining and the other for the culture.
PROCESSING OF CSF AND CSF SHUNT TIP
This included microbiological, biochemical testing and cell count.
1. CELL COUNTING 17
The leucocytes in the CSF were counted by microscopical observation of 
well mixed, uncentrifuged fluid in a slide counting chamber. The relative number of 
polymorphs  and  lymphocytes  were  noted  and  the  number  of  erythrocytes  in 
specimen contaminated with blood.
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COUNTING CHAMBER 
The cell count was performed in a modified Fuchs-Rosenthal slide chamber, 
with a  film depth of  0.2 mm between the counting surface of  the slide and the 
overlying cover-slip.
Normal CSF contains only 0-5 leucocytes/mm3 mainly lymphocytes.
In purulent meningitis there are usually 100-3000 leucocytes/mm3.
DIFFERENTIAL LEUCOCYTE COUNT
This was done using methylene blue staining.                
BIOCHEMICAL ANALYSIS 62
Biochemical tests included measurement of glucose, protein, and globulin. 
The supernatant fluid from centrifuged CSF or uncentrifuged CSF if the sample was 
clear was used.
Measurement of glucose
Specimens  were  transported  to  the  laboratory  without  delay  for  further 
analysis. Total glucose in CSF was measured using a colorimetric technique.
Normal CSF glucose: This is about half to two thirds that found in blood i.e. 
2.5-4.0 mmol/l (45-72mg %).
Measurement of CSF total protein and globulin
Total protein in CSF was measured using a colorimetric technique. 
Total CSF protein is normally 0.15-0.40 g/l (15-40mg%). 
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Pandy’s test done that detected CSF globulin which may be increased in all 
forms of meningitis.
MICROBIOLOGICAL ANALYSIS
MACROSCOPIC EXAMINATION
The  specimen  was  examined  with  the  naked  eye  and  the  following  data 
noted: (1) whether clear, turbid, cloudy, or purulent or blood stained.
CSF samples were centrifuged at 1500 g for atleast 15 minutes. 
A purulent fluid was not centrifuged. 
DIRECT GRAM STAIN 7
In CSF cells and bacteria may be scanty. A thick film was made within an 
area of about 10mm diameter, so that the area to be searched was clearly defined 
with  a  glass  marking  pencil.  The  smear  was  fixed  with  95% methanol  for  one 
minute. Methanol fixation would preserve the morphology of bacteria as well as the 
host cells. The smear was then air dried and stained.   The presence of host cells, 
morphologies, Gram reactions and relative amounts of bacterial cells was identified 
by the Direct Gram stain (Appendix xi).
CULTURE
Immediately after centrifugation of the CSF and the removal of some of the 
deposit  for  Gram film,  the  remainder  of  the deposit  is  seeded on to  the culture 
media. Shunt tip was also used for culturing on to the media by rolling the shunt tip 
on the surface of the media and transferring to a liquid medium using sterile forceps.
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PROCESSING  AND  FURTHER  IDENTIFICATION  OF  AEROBIC 
BACTERIA 7,62
For recovery of non fastidious organisms, the sample was plated on to Mac 
Conkey agar, nutrient agar, and was incubated at 37º c overnight for 24-48 hrs. For 
recovery of fastidious organisms, the sample was plated on to chocolate agar plate/ 
blood agar pate and incubated at 37oC in 5%-10% carbon dioxide in a candle jar for 
atleast 72 hours.
The  plates  were  examined  for  the  growth  at  24  hours.  If  growth  was 
observed,  colony  morphology  and  Gram  stain  morphology  were  studied.  If  no 
growth was observed, the plates were further incubated for the next 48 hours.
The colonies  were  then further processed and identified by means of Gram 
staining, motility, and various biochemical reactions like catalase, oxidase, indole, 
citrate, urease, slide and tube coagulase, triple sugar iron agar test, phenylalanine 
deaminase  test,   modified  Hugh and Leifson O/F  test,  mannitol  motility,  nitrate 
reduction,  methyl  red,  Voges-Proskauer,  bile  esculin  agar  test,  fermentation  of 
sugars like glucose, sucrose, lactose, maltose, mannitol, mannose, ribose by standard 
microbiological techniques as recommended by NCCLS guidelines.
PROCESSING  AND  FURTHER  IDENTIFICATION  OF  ANAEROBIC 
BACTERIA 7,62
The sample was immediately inoculated into semisolid brain-heart infusion 
broth,  and Robertson cooked meat broth enriched with vitamin k1 (1  µg/ml) and 
haemin (5 µg/ml). The broths are overlayed with liquid paraffin and paraffin wax for 
providing anaerobic condition.
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The broths were observed for the appearance of growth, gas production, and 
odour. The sample was inoculated on the CDC Anaerobic Blood Agar supplemented 
with  vitamin  k1 (1  µg/ml)  and  haemin  (5  µg/ml),  Brain  heart  infusion  agar 
supplemented with 0.5% yeast extract and Bile esculin agar (20%), from the broths 
at the bench and immediately incubated in anaerobic jar. Simultaneously plating was 
done in one aerobic blood agar which was incubated aerobically.
Incubation was done in McIntosh Fildes jar with the inlet and outlet closed 
and in 37ºC for 48 hours. Gas pack was used as the reducing agent with palladium as 
the  catalyst.  A  test  tube  containing  a  few  milliliters  of  methylene  blue-sodium 
bicarbonate-glucose mixture was placed in the jars as the indicator.
The plates were then removed and observed for the colony characteristics, 
hemolysis and pigmentation. Gram stained smears of colonies from the plates were 
examined.  Then subculturing simultaneously each colony type  into  an  anaerobic 
plate  as  well  as  into  an  aerobic  plate  for  aerotolerance  tests  were  done  to 
differentiate obligate anaerobes from facultative anaerobes.
PROCESSING AND IDENTIFICATION OF FUNGUS 42
DIRECT MICROSCOPIC EXAMINATION USING WET MOUNT:
A drop from centrifuged CSF sample was put on the slide and covered with a 
coverslip  and  viewed  under  high  power  objective  for  any  fungal  elements  like 
hyphae, pseudo hyphae and yeast cells.
For CSF fungal cultures, two drops well mixed sediment was inoculated into 
Sabouraud dextrose agar and was incubated in air at 30oC for 4 weeks. The colonies 
were further identified by Gram staining and Germ tube test (Appendix xii).
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PROCESSING OF BLOOD 17
Brain-heart infusion broth was used as the primary culture medium for blood 
and subcultures were made into BAP, MAC and NA plates after 48 hours or on 
signs of growth like turbidity, lysis, pellicle & clot formation.  The plates were then 
examined  for  the  growth.  The  colonies  were  then  identified  by Gram stain  and 
various  biochemical  reactions  and  tested  for  its  susceptibility  to  various 
antimicrobial agents.
PROCESSING OF SWABS 17
For  swabs  collected  from the  wound as  well  as  the  environment,  Direct 
Gram stain is performed and cultured on to the MacConkey agar, Blood agar and 
nutrient agar plates. The organisms were isolated and identified and tested for its 
antimicrobial susceptibility.
Processing of Gram-positive cocci in clusters
Catalase
Positive Negative
i) Staphylococcus species i) Streptococcus species
ii) Micrococcus species ii) Stomatococcus species
Staphylococcus species Micrococcus species
1. Modified oxidase - Negative 1. Modified oxidative - Positive
2. Furazolidone 100 µg - Sensitive 2. Furazolidone 100 µg - Resistant
3. Bacitracin 0.04 U - Resistant 3. Bacitracin 0.04U - Sensitive
4. Modified Hugh-Leifson 4. Modified Hugh-Leifson
O/F test - fermentative O/F test - oxidative
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IDENTIFICATION OF CLINICALLY SIGNIFICANT STAPHYLOCOCCAL SPECIES AND SUBSPECIES23
This is done based on the following tests.
Organisms
Slide
coagulase Tube coagulase Urease
Nitrate 
reduction
Polymixin 
B 300U
Bacitracin
10 U
D-
mannitol
D-
mannose
Fructose Sucrose Maltose Lactose D-trehalose Ribose
S aureus + + V + R S + + + + + + + +
S.epidermidis - - + + R S - +sl + + + V - V
S.haemolyticus - - - + S R V - V + + V + V
S.hominis - - + V S S - - + + sl + V V -
S.capitis  subsp. 
capitis - - - V S S + + + +
 sl - - - -
S.capitis  subsp. 
urealyticus. - - + + NA NA + + + + + V
 sl - -
S.  lugdunensis + - V + S/R S/R - + + + + + + -
S. warneri - - + V S S V V + + + sl V + V
S. 
saprophyticus - - + - S S/R V - + + + V + -
S. simulas - - + + S S + V + + +sl + V V
+   −  > 90% strains positive,  -  −  > 90% strains negative,  +sl  -  > 90% strains positive, reaction slow,   V - 11-89% of strains positive
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DEMONSTRATION  OF  SLIME  PRODUCTION  BY  STAPHYLOCOCCUS 
EPIDERMIDIS BY THE TUBE TEST METHOD 23
The test organism was inoculated in tryptic soy broth contained in a standard 
glass culture tube and incubated overnight at 35oC in ambient air. After 18-24 hour 
incubation,  the  broth  is  gently  poured  off,  and  the  tube  was  examined  for  the 
presence  of  a  film lining  the  inner  surface  of  the  tube  which  was indicative  of 
adherent growth. The absence of a film or the mere presence of a ring at the liquid-
air interface was interpreted as negative. The contents of the tubes were removed 
and  the  tube  was  stained  with  safranin  to  demonstrate  the  adherent  growth. 
(Christensen et al 16, Ishak et al 41) 
PHAGE TYPING FOR STAPHYLOCOCCUS AUREUS
Phage typing was done for the all Staphylococcus aureus isolates at Moulana 
Azad Medical College, New Delhi.
DETECTION OF ANTIMICROBIAL SUSCEPTIBILITY PATTERNS
Antimicrobial susceptibility pattern was done in Mueller- Hinton Agar plate 
by Kirby-Bauer Disc diffusion method as recommended by NCCLS (Appendix xiii).
Test inoculum- 0.5 McFarland lawn culture.
Incubation-37 ºC for 16-18 hrs.
Control strains:
Staph aureus-ATCC 25923
           E. coli-ATCC-25922
          Pseudomonas aeroginosa-ATCC 27853.
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The antibiotics used for Gram-positive cocci were 
Penicillin  (10  U),  ampicillin  (10  µg),  oxacillin  (1  µg),  co-trimaxozole  
(25 µg), chloramphenicol (30 µg), gentamycin (10 µg), ofloxacin (5 µg), amikacin 
(30 µg), cefotaxime (30 µg) and vancomycin (30 µg).
The antibiotics  used for  Gram negative bacilli  were ampicillin  (10 mg),  
co-trimaxozole (25 µg), chloramphenicol (30 µg), gentamycin (10 µg), ofloxacin  
(5 µg), amikacin (30 µg), ceftazidime (30 µg), cefaperazone (75 µg),  cefaperazone-
sulbactam (75 µg / 30 µg) and imipenam (10µg).
The  diameters  of  the  zones  of  inhibition  were  interpreted  according  to 
NCCLS standards for each organism.
DETECTION OF BETA-LACTAMASE PRODUCTION59
       All the Gram-positive cocci were tested for β-lactamase production by 
iodometric method. It is based on the principle that penicilloic acid produced by the 
hydrolysis  of Benzylpenicillin by beta-lactamases reduces  iodine and reverse the 
formation of the blue colour when the later complexes with starch.
IODOMETRIC METHOD
REQUIREMENTS
i) 1% soluble starch solution prepared by dissolving the starch at100oC
ii) Iodine reagent consisting of 2.03g iodine and 5.32 g potassium iodide 
in 100 ml distilled water. 
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PROCEDURE 
From  an  overnight  incubation  culture  of  the  test  organism,  a  heavy 
suspension was made (containing 109 colony-forming units/ml)  in 100mm sodium 
phosphate buffer at pH 7.3 containing penicillin at 6 g/litre. A negative control was 
put up without the organisms. An organism known to produce beta-lactamase was 
put as a positive control. The test and the control organisms were inoculated into the 
wells of a microtitre plate. After incubation for 1 hr at 37oC, two drops of freshly 
prepared 1% soluble  starch solution  were added to  each  well.  A drop of  iodine 
reagent was then added. If blue colour was lost within 10 minutes, the presence of 
beta-lactamase was inferred. If, however, the blue colour persisted, the culture was 
considered to be beta-lactamase negative.
DETECTION OF EXTENDED-SPECTRUM BETA-LACTAMASES (ESBLs)
12 isolates showing a zone of inhibition<22 mm for ceftazidime were tested 
for  ESBL  production  as  per  NCCLS  criteria.  Two  methods  were  adapted  for 
detection of ESBLs using standard control strains.
1. COMBINED DISC METHOD 32
 A  combined  disc  method  using  cefaperazone  (75µg)  and  cefaperazone-
sulbactam (75µg/30µg) performed for phenotypic confirmation of ESBL production, 
as recommended by the latest guidelines of  NCCLS.  Organism was considered as 
ESBL  producer  if  there  was  a  more  than  5  mm  increase  in  zone  diameter  of 
cefaperazone-sulbactam disc and that of  cefaperazone disc alone.
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2. DOUBLE DISC SYNERGY TEST 59
In this test a lawn of the test strain on Mueller-Hinton agar plate was exposed 
to discs of ceftazidime (30µg) and augmentin (20 µg amoxycillin/10 µg clavulanic 
acid) arranged in pairs. The discs are arranged so that the distance between them 
was  approximately  twice  the  radius  of  the  inhibition  zone  produced  by  the 
ceftazidime tested on its  own. After  overnight  incubation,  the test  strain  was an 
ESBL producer if the inhibition zone around the ceftazidime disc was extended on 
the side nearest the augmentin disc.
SCREENING  FOR  Amp-C  and  ESBL  PRODUCING  ISOLATESUSING 
MODIFIED DOUBLE DISC SYNERGY TEST 84
12 isolates with zone of inhibition <22mm for ceftazidime were tested. A 0.5 
McFarland of test isolate was swabbed on Mueller-Hinton agar plates and disc of 
ceftazidime (30  µg) was placed adjacent to clavulanic acid (10  µg) and cefoxitin  
(30  µg) was placed at a distance of 20mm from each other. After incubation, an 
enhanced  zone  of  inhibition  between  ceftazidime and clavulanic  acid  were 
interpreted as presumptive evidence for the presence of ESBL. Three isolates that 
showed  reduced  susceptibility  to  ceftazidime  and  cefoxitin  were  considered  as 
screen positive and selected for detection of AmpC β-lactamase.
CONFIRMATORY TEST FOR AmpC β-LACTAMASES
AmpC DISC TEST 84
A lawn culture  of  E. coli ATCC 25922 was prepared on Mueller-Hinton 
Agar plate. Sterile discs (6mm) were moistened with sterile saline and inoculated 
with several colonies of test organism. The inoculated disc was then placed beside a 
cefoxitin disc almost touching on the inoculated plate. The plates were incubated 
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overnight  at  35ºC.  A  positive  test  appeared  as  flattening  or  indentation  of  the 
cefoxitin  inhibition  zone  in  the  vicinity  of  the  test  disc.  A negative  test  had an 
undistorted zone.
MINIMUM INHIBITORY CONCENTERATION(MIC) 59 
            Minimum inhibitory concentration is the least amount of antimicrobial that 
will inhibit visible growth of an organism after overnight incubation
             MIC was done for the drugs benzylpenicillin and ceftazidime by agar 
dilution method for penicillin resistant Gram-positive cocci and ceftazidime resistant 
Gram-negative bacilli respectively. 
PROCEDURE
 Media
19 ml of Mueller-Hinton agar is prepared in tubes, autoclaved and allowed to 
cool in a 50oC water bath. 
Antibiotic
i) Benzyl  pencillin  was  dissolved  in  sterile  water  and  then   serial 
dilutions of the antibiotic from 0.25 mg/l to 128 mg/l were then made 
using Mueller-Hinton broth,  at  10 times the final  concentration of 
antibiotic required. One ml of the antibiotic solution is added to 9 ml 
of the medium. After adding the antibiotic the medium is mixed well, 
and poured into the Petri  dish.  A control  plate  containing the test 
medium  without  the  antibiotic  is  prepared  for  each  series  of  the 
dilution. After the plates have set, they were dried at 37oC.
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ii) In  case  of  ceftazidime,  the  powder  was  dissolved  in  saturated 
NaHCO3 and  sterile  water.  Serial  dilutions  of  the  antibiotic  were 
made from 2 mg/l  to 256 mg/l similarly as mentioned above.
Test inoculum
The test strains were inoculated in peptone water and its turbidity adjusted to 
0.5 McFarland standard to get a working inoculum of 107  cfu/ml. A micropipette 
was used to deliver 2  µl so that the final inoculum on the agar surface would be  
104 cfu/ml.
 Controls 
Standard control strains were used in every batch of MIC tests.
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PROCESSING OF CSF
MICROBIOLOGICAL BIOCHEMICAL CELL COUNT
Macroscopic Microscopic
1.  Protein 1.  Total
1.  Clear 2.  Glucose 2.  Differential
2.  Turbid 3.  Pandy's test for      count
3.  Blood stained     globulin
4.  Purulent
Direct Culture
1.  Gram stain
2.  Direct wet mount
     for fungal elements
Aerobic Anaerobic Fungal
Non-Fastidious Fastidious RCM Sabouraud
BHI semisolid broth Dextrose agar
MAC, NA BAP / CAP CDC anaerobic
blood agar
Bile esculin agar
Incubate at 37oC Incubate in candle Incubate in Incubate at 30oC
for 24-48 hrs jar  at 5-10% CO2 McIntosh Fildes jar for 4 weeks
for 24-72 hrs for 48 hrs
    Further identified by
Further identified by i)  Gram stain
i)  Colony morphology ii) Germ tube
ii) Gram stain
iii) Biochemical reaction
iv) Antimicrobial susceptibility pattern
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OBSERVATION AND RESULTS
TABLE 1
SEX DISTRIBUTION
Sex n = 428 Percentage
MALE 238 55.6%
FEMALE 190 44.4%
                         
No significant predilection was observed between the sexes.  
TABLE 2
AGE DISTRIBUTION
Age n=428 Percentage
0-6 MONTHS 72 16.8
6-12 MONTHS 46 10.7
1-4 YEARS 45 10.5
5-8 31 7.2
9-12 26 6.1
13-16 28 6.5
17-20 39 9.1
21-24 23 5.4
24-28 25 5.8
29-32 26 6.1
33-36 19 4.4
37-40 14 3.3
41-44 11 2.6
45-48 7 1.6
49-52 6 1.4
53-56 5 1.2
57-60 5 1.2
   
Patients in the age group less than 16 were considered under the paediatric 
category-248(57.9%)
Patients  in  the  age  group  more  than  16  were  considered  under  adult 
group-180 (42.1%)
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                                                                  TABLE 3
ETIOLOGY OF HYDROCEPHALUS NECESSIATING SHUNT
Reason for shunt
Children
(n=248)
Adult
(n=180)
Total
(n=428)
Preceding meningitis 54 (21.8%) 51 (28.3%) 105 (24.5%)
CNS tumour 39 (15.7%) 90 (50%) 129 (30.1%)
Congenital malformations 135(54.4%) - 135(31.5%)
1) Aqueductal stenosis 26 (10.5%) - 26 (6.1%)
2) Dandy-walker syndrome 22 (10.5%) - 22 (5.1%)
3) Myelomeningocele 14 (5.6%) - 14 (3.3%)
Other congenital malformations 73 (29.4%) 73 (17.1%)
Idiopathic 15 (6%) 39 (21.7%) 54 (12.6%)
Subarachnoid haemorrhage 5 (2%) - 5 (1.2%)
Space occupying lesions were observed in 50% of adults patients, where as 
in children congenital malformations were more common. Meningitis was observed 
as a precipitating factor in both categories.
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TABLE 4
CLINICAL FEATURES OF PATIENTS
Clinical Features
Children
(n=77)
Adult
(n=43)
Total
(n=120)
Fever 34 11 45(37.5%)
Seizures 29 9 38(31.7%)
Headache 42 24 66(55%)
Vomiting 53 26 79(65.8%)
Altered consciousness 31 21 52(18.3%)
Abdominal signs 12 10 22(18.3%)
Wound changes 7 9 16(13.3%)
Displaced shunt 9 7 16(13.3%)
CSF leak 8 4 12(10%)
Symptoms such as vomiting, headache, altered consciousness and fever were 
present in children and adults. Seizures were common in children.
TABLE 5
PATIENTS CATEGORY FOR THE STUDY
                    
Study population Total no Cases selected
Culture positive 
cases
Primary VP shunt Insertions 404 96 36
Old cases with Multiple revisions
(n=24)
24 24 5
TOTAL 428 120 41
404  patients  were  treated  surgically  for  hydrocephalus  during  the  study 
period of which 96  showed signs of shunt malfunction. 2 of them had dual episodes 
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of malfunction. Additional 24 patients who had undergone surgery previously  and 
presented with malfunction were also included in the study. Out of 96 cases, 36 
cases were proved culture positive with an infection rate of 8.9%. Two patients had 
recurrence of infection during the study period.  In 24 cases with multiple revisions, 
the infection rate was 20.8% involving 5 patients.     
                      
 TABLE 6
DURATION BETWEEN INSERTION OF SHUNT AND ONSET OF 
INFECTION IN PRIMARY SHUNT INSERTION CASES
Duration
Malfunction
(n=96)
Infection
(n=36)
0-1 MONTH 42 (43.8%) 23(63.9%)
1-2 MONTHS 23 (23.9%) 8 (22.2%)
2-3 MONTHS 18 (18.8%) 3(8.3%)
3-6 MONTHS 13 (13.3%) 2 (5.6%)
In 24 cases of malfunction, multiple revisions were done before the study 
period. All cases presented were more than six months duration.
About 63.9% infection presented with in one month, 86.1% presented with in 
2 months and and 94.4% presented with in 3 months and the remaining presented 
with in 6 months. No case of infection was present beyond six months during the 
study period.
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TABLE 7
                  
AGE AS A RISK FACTOR
Age n=428 No Infected Percentage
0-6 MONTHS 72 13 18.1
6-12 MONTHS 46 5 8.7
1-4 YEARS 45 6 10.9
5-8 31 2 6.4
9-12 26 2 7.7
13-16 28 1 3.6
17-20 39 3 7.7
21-24 23 1 4.3
24-28 25 2 8
29-32 26 2 7.7
33-36 19 1 5.3
37-40 14 1 7.1
41-44 11 1 9.1
45-48 7 0 0
49-52 6 0 0
53-56 5 0 0
57-60 5 0 0
                                         
Age < 6 months was found to be a significant risk factor for shunt infection 
as 13 cases (18.1%)  were within 6 months  of age as compared to only < 11% in all 
other age groups.
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TABLE 8
UNDERLYING CONDITION OF THE PATIENT AS A RISK FACTOR
Reason for shunt
Children
(n=248)
Adult
(n=180)
Total
(n=428)
Total 
cases
Total
Infected
Total 
cases
Total 
infected
Total
Cases
Total 
infected
Preceding meningitis 54 11(20%) 51 3 105 14(13.3%)
CNS tumour 39 3(7%) 90 7 129 10(7.7%)
Congenital 
malformations
-
1) Aqueductal stenosis 26 2(7.7%) - 26 2(7.7%)
2) Dandy-walker 
syndrome
22 2(9.1%) - - 22 2(9.1%)
3) Myelomeningocele
    
14 3(21.4%) - 14 3(21.4%)
Other congenital 
malformations
73 6(7.9%) - 73 6(7.9%)
Idiopathic 15 1(6.7%) 39 1 54 2(3.7%)
Subarachnoid 
haemorrhage
5 1(20%) - 5 1(20%)
Surgery for a  postinfectious  and post  hemorrhagic  hydrocephalus  showed 
highest  incidence  of  shunt  infection  in  both  adult  and  children.  Among  the 
congenital  malformations  infection  rates  were  higher  in  patients  with 
myelomeningocele.
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TABLE 9
SIGNIFICANCE OF CLINICAL FEATURES AS INDICATORS 
OF  SHUNT INFECTION
CLINICAL FEATURES TOTAL CASES
(n=120)   
PERCENTAGE IN 
INFECTED
Fever 45 60%
Seizures 38 52.6%
Headache 66 21.2%
Vomiting 79 27.8%
Altered consciousness 48 54.2%
Abdominal signs 22 31.8%
Wound changes 16 50%
Displaced shunt 16 50%
CSF leak 12 66.7%
Symptoms  such  as  fever,  seizures,  altered  consciousness,  CSF  leak, 
displaced shunt were associated with a high risk of infection.  Headache, vomiting 
abdominal signs were less specific signs of infection.
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TABLE 10
CSF CELL COUNT AND BIOCHEMICAL PARAMETERS AS 
PREDICTORS OF SHUNT INFECTION
I
Variable
CSF WBC > 100 mm³
Infected cases
(n=41)
Non infected cases
(n=79)
Positive 26 3
Negative 15 76
 
Sensitivity- 63.4%, Specificity- 96.2%
II
Variable
CSF Neutrophils>10%
Infected cases 
(n=41)
Non infected cases
(n=79)
Positive 28 4
Negative 13 75
Sensitivity- 68.3%, Specificity- 94.9%
III
Variable
CSF protein>50 mg/dl
Infected cases 
(n=41)
Non infected cases
(n=79)
Positive 25 13
Negative 16 66
Sensitivity- 61%, Specificity- 83.5%
IV
Variable
CSF glucose<40 mg/dl
Infected cases 
(n=41)
Non infected cases
(n=79)
Positive 24 6
Negative 17 73
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Sensitivity- 58.5%, Specificity- 92.4 %
Using  Chi-square  test  the  values  of  the  infected  group  was  found  to  be 
significantly different from the non infected group with P<0.05
Abnormal  biochemical  values  can  indicate  the  presence  of  infection  but 
normal biochemical parameters cannot rule out the presence of infection. They are 
useful in starting empirical antibiotic therapy till culture results are awaited.
TABLE 11
GRAM STAINING AS A PREDICTOR OF  SHUNT INFECTION
I
Total isolates=49 Gram staining positive Percentage
Gram positive n=27 9 33.3%
Gram negative n=22 19 86.4%
II
Gram staining Infected cases  
(n=41)
Non infected cases
(n=79)
Positive 26 0
Negative 15 79
Sensitivity- 63.4%, Specificity- 100 %
The  correlation  of  Gram  staining  and  CSF  biochemical  analysis  is  very 
useful in choice of antibiotic for empirical antibiotic theraphy till culture results are 
available.
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TABLE 12
PATHOGENS ISOLATED IN 41 CASES OF SHUNT INFECTION
Organisms Total No = 50 Percentage
GRAM POSITIVE COCCI
Staphylococcus epidermidis* 16 32
Staphylococcu aureus* 9 18
Micrococcus luteus 1 2
Enterococcus faecalis 1 2
GRAM NEGATIVE BACILLI
Escherichia coli* 5 10
Klebsiella pneumoniae 6 12
Klebsiella oxytoca* 2 4
Pseudomonas aeroginosa* 5 10
Acinetobacter baumannii* 2 4
Citrobacter diversus 1 2
Morganella morganii 1 2
FUNGUS
Candida albicans 1 2
Staphylococcus  epidermidis was  the  commonest  pathogen  followed  by 
Staphylococcus  aureus,  Escherichia  coli,  Klebsiella  species,  and Pseudomonas 
aeroginosa.
  
* In mixed infections the organisms isolated were 
i)  Morganella  morganii  with Escherichia  coli,  ii)  Staphylococcus  aureus  with 
S.  epidermidis,  iii) Staphylococcus  aureus  with Acinetobacter  baumannii,  and 
iv) Klebsiella oxytoca with Pseudomonas aeroginosa.
    
TABLE 13
Recurrence First episode Second episode
PATIENT-1 Klebsiella pneumoniae Klebsialle pneumoniae + 
Pseudomonas aeroginosa + 
Candida albicans
PATIENT-2 Staphylococcus 
epidermidis
Staphylococcus epidermidis  
+ Klebsiella pneumoniae
52
                                                          TABLE 14
                MONOMICROBIAL AND POLYMICROBIAL INFECTIONS
Children
(n=30)
Adult
(n=11)
Total=41
MONOMICROBIAL 29 8 37 (90.2%)
POLYMICROBIAL 1 3 4    (9.8%)
Most of the infections were monomicrobial in nature.
Two cases of recurrent infection were polymicrobial in nature.
TABLE 15
ORGANISMS IN EARLY AND LATE INFECTION
Organisms Early infection Late infection
Staphylooccus epidermidis 16 0
Staphylococcus aureus 9 0
Micrococcus luteus 1 0
Enterococcus faecalis 1 0
Escherichia coli 3 2
Klebsiella pneumoniae 5 1
Klebsiella oxytoca 2 0
Pseudomonas aeroginosa 3 1
Acinetobacter baumannii 1 1
Citrobacter diversus 1 0
Morganella morganii 0 1
Candida albicans 1 0
Gram-positive cocci produced early infection. Infection due to Gram-negative bacilli 
resulted in early and late infection.
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                                                    TABLE 16
  
SLIME PRODUCTION IN S.EPIDERMIDIS
S. epidermidis
Slime positive Slime negative
NO % NO %
16 10 (62.5)% 6 (37.5)%
62.5 % of the S. epidermidis strains were positive for slime production.
TABLE 17
BACTEREMIA IN INFECTED CASES
Total infected cases Positive %
41 2 4.9%
Bacteremia was detected in 4.9% of the infected cases and carried grave prognosis.
Klebsiella pneumoniae was isolated in both the cases
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TABLE  18
ANTIMICROBIAL SENSITIVITY PATTERN OF GRAM-POSITIVE COCCI
Organisms Penicillin (10 U)
Ampicillin 
(10 µg)
Oxacillin 
(1 µg)
Chloramphenicol 
(30 µg)
Ofloxacin 
(5 µg)
Co-
trimoxozole 
(25 µg)
Cefotaxim
e (30 µg)
Gentamici
n (10 µg)
Vancomycin 
(30 µg)
S. 
epidermidis  
(16)
6
(37.5%)
10
(68.7%)
12
(75%)
12
(75%)
13
(81.3%)
10
(68.7%)
12
(75%)
12
(75%)
16
(100%)
S. aureus (9) 3
(33.3%)
6
(66.7%)
7
(77.8%)
7
(77.8%)
8
(88.9%)
7
(77.8%)
7
(77.8%)
7
(77.8%)
9
(100%)
Micrococcus 
luteus (1)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
Enterococcu
s Faecalis
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
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TABLE 19
ANTIMICROBIAL SENSITIVITY PATTERN OF GRAM-NEGATIVE BACILLI
Ampicillin 
(10 µg)
Ofloxacin 
(5 µg)
Amikacin
(30µg)
Chloramphenicol 
(30 µg)
Co-
trimoxozole 
(25 µg)
Ceftazidime
(30µg)
Cefaperazone
(75µg)
Cefaperazone
+Sulbactam
(75/30µg)
Imipenam
(10µg)
E. coli (5) 3
(60%)
4
(80%)
4
(80%)
4
(80%)
3
(60%)
3
(60%)
3
(60%)
5
(100%)
5
(100%)
K. 
pneumoniae 
(6)
4
(66.7%)
5
(83.3%)
4
(66.7%)
5
(83.3%)
4
(66.7%)
4
(66.7%)
4
(66.7%)
5
(83.3%)
6
(100%)
K. oxytoca 
(2)
1
(50%)
2
(100%)
2
(100%)
1
(50%)
2
(100%)
2
(100%)
2
(100%)
2
(100%)
2
(100%)
P. 
aeruginosa 
(5)
3
(60%)
4
(80%)
5
(100%)
4
(80%)
4
(80%)
4
(80%)
4
(80%)
5
(100%)
5
(100%)
Acinetobacte
r
baumannii  
(2)
1
(50%)
2
(100%)
2
(100%)
1
(50%)
2
(100%)
2
(100%)
2
(100%)
2
(100%)
2
(100%)
Citrobacter  
diversus (1)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%)
1
(100%
Morganella  1 1 1 1 1 1 1 1 1
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morganii (1) (100%) (100%) (100%) (100%) (100%) (100%) (100%) (100%) (100%)
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TABLE 20
BETA–LACTAMASES PRODUCTION IN GRAM-POSITIVE COCCI
Organisms NO %
S.epidermidis (16) 6       37.5%
S.aureus(9) 3 33.3%
β-lactamase production was detected in 37.5% of the isolates in S. epidermidis and
33.3% of the isolates in S. aureus 
TABLE 21
EXTENDED-SPECTRUM β-LACTAMASES (ESBLs) PRODUCTION IN 
GRAM-NEGATIVE BACILLI
Organisms NO %
Escherichia coli           (5) 2 40 %
Klebsiella pneumoniae(6) 2 33.3%
Pseudomonas aeroginosa(5) 1 20%
ESBLS were detected in  Escherichia coli  (40%), Klebsiella pneumoniae  (33.3%), 
and Pseudomonas aeroginosa (20%)
              
One strain of Klebsiella pneumoniae was an AmpC producer.
                                
                                      
TABLE 22
MIC OF BENZYL PENCILLIN FOR PENCILLIN RESISTANT 
GRAM-POSITIVE STRAINS
Organism 8 µg/dl 16 µg/dl 32 µg/dl MIC 50
S.epidermidis(10) 6 2 2 8µg/dl
S.aureus(6) 1 1 4 32µg/dl
MIC  break  points  of  penicillin  resistant  Gram-positive  strains  were  between  
8-32 µg/dl  with a MIC 50 of 8µg/dl for S.epidermidis  and MIC50 of 32µg/dl for 
S.aureus
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TABLE 23
MIC OF CEFTAZIDIME FOR CEFTAZIDIME RESISTANT 
GRAM-NEGATIVE STRAINS
Organism 32 µg/dl 64 µg/dl 128 µg/dl MIC50 
Escherichia coli (2) 1 0 1 128 µg/dl
Klebsiella  
pneumoniae (3)
0 1 2 128 µg/dl
Pseudomonas 
aeroginosa (1)
0 0 1 128 µg/dl
MIC of six ceftazidime resistant Gram-negative bacilli were between 32-128µg/dl 
with a MIC 50 of 128 µg/dl
TABLE   24
OUTCOMES IN INFECTED PATIENTS
Children(n=30) Adult(n=11) Total =41
Survived 29 9 38
Death 1 2 3
The overall mortality rate was 7.3% among the shunt infected patients.
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DISCUSSION
Ventriculoperitoneal shunt  placement is  a relatively common neurological 
procedure  performed  for  the  treatment  of  hydrocephalus  as  well  as  associated 
conditions in which the natural flow of cerebrospinal fluid is obstructed. Shunts are 
quite susceptible to bacterial  infection,  which contribute to excess morbidity and 
mortality.
In our study males  constituted 55.6% and females constituted 44.4%. No 
significant predilection was observed between the sexes (Table 1).
In our study 248 (57.9%) patients in age groups less than 16 were grouped 
under paediatric category.  180(42.1%) patients in the age group more than 16 were 
considered under adult category as per the criteria fixed by Kuo-Wei-Wang et al.51 
(Table 2).
In this  study the etiology of hydrocephalus that necessitated shunt among 
children  were  preceding  meningitis  (21.8%),  CNS  tumour  (15.7%),  congenital 
malformations like aqueductal  stenosis  (10.5%), Dandy-walker syndrome (8.9%), 
myelomeningocele  (5.6%),  idiopathic  (6%) and subarachnoid haemorrhage (2%). 
Thus in children congenital malformations were common followed by meningitis. 
Among adults, space occupying lesions were common (50%) followed by preceding 
meningitis (28.3%) and idiopathic (21.7%) (Table 3).
In a study done by  Latifa T.F et al.52, on CSF shunt infections in children the 
indications  of  shunt  were  myelomeningocele  (20%),  aqueductal  stenosis  (18%), 
CNS  tumour  (13%),)  preceding  meningitis  (6%),  preceding  SAH  (3%),  other 
congenital malformations (13%), other acquired etiology (11), idiopathic (18%).
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In our study, the clinical features of the patients with shunt malfunctions due 
to  both  mechanical  causes  or  infection  were  fever  (37.5%),  seizures  (31.7%), 
headache (55%), vomiting (65.8%), altered consciousness (43.3%), abdominal signs 
(18.3%), wound changes (13.3%), displaced shunt (13.3%), and CSF leak (10%). 
Symptoms  such  as  headache,  vomiting,  fever  and  altered  consciousness  were 
common  in  both  categories.  Seizures  were  commonly  observed  in  children. 
Abdominal  signs,  wound  changes  and  displaced  shunts  were  common  in  few 
patients (Table 4).
Alexa et al.1 have observed the symptoms of shunt malfunction are the same 
as  seen  with  the  initial  hydrocephalus  such  as  headache,  vomiting  and  altered 
consciousness and in addition to these there were shunt specific findings, such as 
fluid  around  the  shunt,  i.e.,  CSF leak,  abdominal  pain  or  distension.  Symptoms 
referable to infection such as fever, seizures may be seen. Our study findings were 
similar with this study.
The rate  of  cerebrospinal  shunt  infection  varied  considerably in  different 
studies, ranging from 0.33% to 39 %.8, 26, 55, 75
In  our  study  in  about  404  patients,  with  primary  shunt  insertions,  96 
malfunctions occurred (23.7%) of which 36 were infected after their primary shunt 
surgery resulting in an infection rate of 8.9 %. Two cases had recurrence of infection 
during the study period. In 24 cases with multiple revisions, the infection rate was 
20.8%, involving 5 patients indicating higher infection rate compared to primary 
shunt surgery (Table 5). Our results correlated with the infection rate of many other 
studies.
Calderri  et  al.12 the  authors  of  department  of  neurosurgery from catholic 
University Medical School, Rome have analysed the incidence of early mechanical 
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and infective  CSF complications  in  170 patients  with  hydrocephalus  in  the  first 
postoperative year. They found that about 45.9% of the patients presented with one 
shunt malfunction three quarters of which were due to mechanical causes and one 
quarter due to infection.
Recently,  Borgbjerg  and  associates60 studied  884  shunt  patients  who 
underwent  placement  of  newshunt  in  Copenhagen  from 1958-1989.  The  overall 
infection rate in their study was 7.4 % (5.7-9.3%). 
Gardner P et al.30 in his work on Infections of central nervous system shunts 
had  quoted  about  1  out  of  every  10  ventricular  shunts  for  hydrocephalus  will 
become infected. 
George et al.33 however, showed that the operative incidence of infection in a 
patient undergoing a third or greater revision was significantly greater compared to 
one underlying a first or second revision.
Among  paediatric  patients,  the  majority  of  shunt  infections  occurred 
relatively soon after  the placement  of  shunt.18.  In  our  study 63.9% of  infections 
occurred with in one month, 86.1% in 2 months and 94.4% infections presented with 
in three months. All the cases of infection in primary shunt surgery presented within 
six months (Table 6).
This was similar to that reported by Choux et al15 . In their study on reducing 
the incidence of shunt infection, they had roughly 66% of shunt infections diagnosed 
with in one month after surgery, and close to 80% manifested by 6 months. 
In one larger series of paediatric patients with extended follow-up, Casey and 
Colleagues13 reported  that  among  children  with  shunted  hydrocephalus  who 
underwent a first shunt revision for infection, 92% of infections occurred with in 3 
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months of the initial shunt placement.
In an effort to reduce the rate of infection associated with the use of shunt 
devices, attempts were made to identify the risk factors. In general, the factor most 
frequently associated with an increased rate of shunt infection was the age of the 
patient. Neonates and very young children were at greater risk.22
In our study, in about 43 cases, 13 cases (18.1%) were with in six months of 
age, as compared to < 11% among all the other age groups (Table 7). In their cohort 
study, Casey and colleagues13 reported that children aged 6 months or younger had a 
19% rate of infection, versus a rate of 7 % among older children.
Young age (less than 6 months) seemed to represent the main risk factor, and 
this was related both to the immunologic deficiency and to the particular features of 
residential flora in this group.18
Pople et al.12 in their study on etiological factors of CSF shunt infections in 
infants had shown an infection rate of 15.7% for infants younger than 6 months of 
age , as compared with  only 5.6%  for older children . This might be due to the age 
related changes in the skin and its resident bacterial flora with the density of aerobic 
cocci being higher in infancy.
Along with age, numerous other factors such as reason for shunt surgery, 
previous shunt   history, number of early revisions have been examined for their role 
in shunt infection.22
In  our  study,  surgeries  for  myelomeningocele  (21.4%)  postinfectious 
hydrocephalus (20%), posthaemorrhagic hydrocephalus (20%) showed the highest 
incidence of shunt infections in children.  Among adults infection rates were higher 
in tumour patients (7.7%) followed by postinfective hydrocephalus (5.9%) (Table 
62
8). 
Dallacasa18 and  associates  reported  that  half  of  the  children  in  the  post-
infectious-posthaemorrhagic hydrocephalus group had at least one episode of shunt 
infection by the end of one year. Also children with myelomeningocele might be at 
greater risk for infection than with congenital hydrocephalus.2
According to various studies the clinical manifestations of shunt infections 
were  variable.  In  trying  to  assess  the  significance  of  the  various  symptoms  in 
patients  with shunt  infection symptoms such as  CSF leak (66.7%), fever  (60%), 
altered  consciousness  (54.2%),  seizures  (52.6%),  displaced  shunt  (50%),  were 
associated with a high risk of infection. Headache, vomiting, abdominal signs and 
wound changes were also observed (Table 9).
Many studies on  CSF shunt infections had shown  that fever may be present 
in as few as 14% to as many as 92% of shunt infection  and about 65% of the 
patients had reported to have change in mental status.10
In our study abdominal signs were present in 22 patients, 31.25% of whom 
developed shunt infection (Table 9).
In the study done by Nelson et al.65, abdominal complaints were present in 
19-36% of the cases. Infections with wound dehiscence as well as drainage of the 
purulent material are obvious signs.
Odio et al.67 showed in 18-36% of cases associated wound infection may be 
present. In our study, wound changes were observed ion 16 patients, 31.8% of which 
developed shunt infection.
The clinical characteristics of my study correlated with various other studies.
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CSF examination is useful in the investigations of shunt infection. Our study 
showed CSF pleocytosis  WBC> 100 mm³ (sensitivity-63.4%, specificity-96.2%), 
neutrophilia >10% (sensitivity -68.3%, specificity-94.9%), high protein level > 50 
mg/dl  (sensitivity-61%,  specificity-83.5%),  low  glucose  level<40mg/dl 
(sensitivity-58.5%, specificity-92.4%)  (Table 10). 
Our study was comparable with the study done by Cheng-Chou Lan et al.14 
on Early diagnosis of ventriculoperitoneal shunt infections and malfunctions, which 
showed CSF WBC >100 mm3 (sensitivity-60%, specificity-96%), CSF neutrophils 
>10% (sensitivity-90%, specificity-85%), CSF protein >50 mg/dl (sensitivity-80%, 
specificity-84%), CSF glucose <40 mg/dl (sensitivity-60%, specificity-93%).
Abnormal biochemical values indicate the presence of infections but normal 
biochemical parameters cannot rule out the presence of infections. They are useful 
in starting empirical antibiotic therapy till culture results are obtained.
In our study Gram staining was useful in detecting Gram-negative infections 
as Gram staining was positive in 86.4% of cases. In case of Gram-positive infections 
Gram staining  was  positive  only in  33.3% of  cases.  The  overall  sensitivity was 
63.4% but specificity was 100% (Table 11).
Odio et al.67 had showed Gram stain was positive only in 46% of the episodes 
and Gram-positive cocci were isolated in 75% of the patients.
Nelson et al.65 had showed Gram stains were highly positive in S. aureus and 
Gram-negative infection (82 and 91%) but may be misleading in  S. epidermidis in 
which Grams stains may be positive in as few as 4% of shunt infections. 
This correlated with our observation where  S. epidermidis was detected in 
only 3.7% of infection.
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The correlation between Gram staining and CSF neutrophilia is very 
useful in choice of antibiotic for empirical theraphy.
Since  shunt  infections  are  life  threatening  early  antibiotic  therapy  is 
essential. Gram staining and neutrophil counts can be of immense help in ensuring a 
good outcome.
In my study infecting pathogen was a single organism in 37 cases (90.2%) 
and mixed infections occurred in 4 cases (9.8%). Two patients had recurrence of 
infection i.e., more than one episode (Table 14).
Staphylococcus  epidermidis (32%)  was  the  commonest  organism isolated 
followed  by  Staphylococcus  aureus  (18%),  Klebsiella  pneumonia  (12%), 
Escherichia coli (10%),   Pseudomonas aeroginosa (10%), Klebsiella oxytoca (4%),  
Acinetobacter  baumannii  (4%).   The  remaining  organisms  isolated  were 
Micrococcus  luteus,  Enterococcus  faecalis,  and  Citrobacter  diversus  all 
contributing  to  about  2%.  Morganella  morganii (2%)  was  isolated  in  a  mixed 
infection  along  with  E.  coli. One  Candida  albicans was  isolated  in  a  recurrent 
infection (Tables 12 & 13). 
Bruce  A.  Kauffman  article10 on  Infections  of  cerebrospinal  fluid  shunt 
infections revealed the common etiological agents in shunt infections as follows: 
staphylococcus epidermidis is the most frequently isolated of the organisms being 
responsible for about 47-64% of the infections. Staphylococcus is the next common 
organism,  occurring  in  12-29% of  infections.  Gram-negative  organisms,  usually 
Escherichia coli and Klebsiella species, are responsible for the next most frequent 
group  of  infections  having  an  incidence  ranging  from  6-20%. Proteus and 
Pseudomonas species are also frequently isolated. Streptococcal species are found in 
8-10%  of  infections.  A  variety  of  much  less  common  organisms  make  up  the 
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remainder  of  the  infections,  including  fungi  and  other  commensal  microbes.  In 
approximately 10-15% mixed infections occur.
The  above  results  correlated  well  with  the  results  of  the  present  study 
Meivoritch  et  al58 accounted  Coagulase  negative Staphylococci for  28%  and 
Staphylococcus aureus for 14% of the initial infectious episodes that occurred in  
46 episodes involving 32 patients. Eight patients (25%) had more than one episode.
Sharpio  S  et  al.82 showed  the  infecting  pathogens  as  Staphylococcus 
epidermidis  (45%),  Staphylococcus  aureus  (20%),  Micrococcus  (5%). Gram-
negative bacilli (15%).
In our study, the organisms isolated in early infection were mostly Gram-
positive cocci i.e. Staphylococcus epidermidis and Staphylococcus aureus; where as 
Gram-negative organisms were isolated from both categories and with significant 
isolation in late infection (Table 15).
In  16  episodes  of  infection  caused  by  Staphylococcus  epidermidis  
10 (62.5%) episodes of infection were caused by slime producing  Staphylococcus 
epidermidis and  6  (37.5%) by non slime  producing  Staphylococcus  epidermidis  
(Table 16).
In  a  study by Diaz  Mitomaf  et  al20 on  19  episodes  of  shunt  infection,  
11  episodes  were  caused  by  slime  producing  coagulase  negative  Staphylococci 
(CNST) and 8 episodes by non slime producing CNST. He also showed failure to 
eradicate  the  infecting  organisms  by  antimicrobial  therapy  that  occurred  more 
frequently with infections due to slime producing CNST.
Various studies had shown that slime producers account for 60-80% of the 
coagulase negative Staphylococci isolated from shunt infections.20, 37, 97
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In our study the protocol was to replace the shunt whenever Staphylococcus 
epidermidis was isolated.
In this  study,  bacteremia was detected in  4.9% of  the infected cases  and 
carried grave prognosis. The organism isolated was Klebsiella pneumoniae in both 
cases. The mortality rate was 100% in these 2 patients with positive blood cultures, 
as  compared  to  the  overall  mortality  rate  of   7.3% among  the  infected  patients 
(Tables 17, 23 & 24).
Latifa  et  al.52  in  his  study  on  CSF  shunt  infections  had  said  that  blood 
cultures were mostly negative due to the absence of direct access to blood stream.
Odio  et  al.67 had  showed  blood  cultures  positivity  in  29%  involving  
59 infectious episodes in 51 patients.
All  the  Gram-positive  cocci  showed  100%  sensitivity  to  vancomycin. 
Staphylococcus epidermidis showed 81.3% sensitivity to ofloxacin, 75% sensitivity 
to oxacillin, cefotaxime, chloramphenicol and gentamicin.  Staphylococcus aureus 
showed 88.9% sensitivity to ofloxacin, 77.8% sensitivity to oxacillin, cefotaxime, 
gentamicin,  chloramphenicol,  co-trimoxozole,  66.7%  sensitivity  to  ampicillin. 
Micrococcus  luteus and  Enterococcus  faecalis were  sensitivity  to  all  drugs  
(Table 18).
All  the  Gram-negative  bacilli  showed  100%  sensitivity  to  Imipenam, 
cefaperazone-sulbactam with  the  exception  of  Klebsiella  pneumoniae  which was 
83.3  %  sensitive  to  cefaperazone-sulbactam.  Escherichia  coli  showed  80% 
sensitivity  to  ofloxacin,  amikacin,  and  chloramphenicol.  Klebsiella  pneumoniae 
showed  83.3% sensitivity  to  ofloxacin  and  chloramphenicol,  Klebsiella  oxytoca 
were  100%  sensitivity  to  ofloxacin,  amikacin,  ceftazidime  and  cefaperazone. 
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Citrobacter  diversus and  Morganella  morganii were  sensitive  to  all  drugs. 
Pseudomonas aeroginosa showed 100% sensitivity to amikacin, and Acinetobacter 
baumannii  showed  100%  sensitivity  to ofloxacin,  amikacin,  ceftazidime  and 
cefaperazone (Table 19).
In our study   22.2% of the isolates were methicillin resistant Staphylococcus 
aureus (MRSA) and 25% of the isolates were methicillin resistant  Staphylococcus 
epidermidis (MRSE).
 MRSA and MRSE mostly  present  in  old  patients  and  patients  who had 
undergone various other neurosurgical procedures.
         In a study by Kuo-Wei Wang et al.51 oxacillin resistant Staphylococcal strains 
accounted for 33% of the episodes.
β-lactamase  production  was  detected  in  37.5%  of  the  isolates  in  
S. epidermidis and  33.3% of the isolates in S. aureus (Table 20).
In  our  study  ESBL  producing  strains  were  detected  in  Klebsiella  
pneumoniae (33.3%) Escherichia coli (40%), Pseudomonas aeroginosa (20%). one 
strain of Klebsiella pneumoniae showed production of Amp C beta-lactamase (Table 
21).  These  strains  were  mostly  present  in  cases  of  multiple  shunt  revisions  and 
recurrence.
In  this  study,  minimum  inhibitory  concentration  break  points  of  benzyl 
penicillin for penicillin resistant  Staphylococcus species were between 8 µg/ml to 
32 g/dl (Table 22). MIC breakpoints of ceftazidime resistant Gram-negative bacilli 
were between 32 g/dl-128 g/dl with MIC50 of 128 µg/dl (Table 23).
In our study most strains were sensitive to all drugs suggesting that they have 
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been derived from patient’s  residential  flora.  A few strains were resistant. Those 
bacteria were isolated from patients who had associated CSF leak, displaced shunt, 
or  wound  infection  suggesting  the  possibility  of  contamination  from  the 
environment.
Various studies revealed the source of infection in majority of the cases in 
cases of Gram-positive shunt infections were commensals of the skin, a result of 
direct  contamination during surgery  3,  78.  In Gram-negative infections,  they could 
probably be introduced during surgery. Another probable mechanism is retrograde 
infection,  in  which  an  asymptomatic  perforation  of  the  bowel  leads  to  distal 
contamination of the VP shunt catheter and retrograde progression of infection.76, 86.
Duhaime  et  al  21 in  their  study  concluded  that  the  bacteria  most  often 
associated  with  shunt  infections  were  airborne  in  the  operating  room,  and  are 
distributed in the highest concentration near the surgical team.
In our study endogenous swabs taken from the external auditory canal, nose, 
umbilicus revealed  Staphylococcus epidermidis and  Staphylococcus aureus which 
was found to be phenotypically similar with the isolates identified from the CSF 
samples  as the antibiotic susceptibility patterns were the same. This showed that the 
pathogens would most likely be the resident flora of the skin. Subsequent Phage 
typing also showed correlation.
In  this  study  environmental  sampling  done  in  neurosurgical  ward, 
neurosurgery theatre using swab and open plate method grew methicillin resistant  
Staphylococcus  strains,  Klebsiella  pneumoniae  suggesting  the  possibility  of 
nosocomial infections.
Phage typing of the isolate and environmental samples of  Staphylococcus 
69
aureus done which showed correlation. Phage 622 was the most common. Some 
strains were untypable.
Infected  patients  were  treated  with  external  ventricular  drainage  with 
appropriate  antibiotics.  An empirical  regimen of  ampicillin-cloxacillin  (500 mg  
IV BD) followed by treatment based on sensitivity pattern was instituted among 
most patients. Most of the patients improved with in one week and new shunt was 
inserted subsequently. 2 patients had recurrence of infection with bacteremia and 
died subsequently (Table 24).
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SUMMARY
• This study was done for a period of 18 months involving 428 patients of both 
sexes and age group ranging from 0-60 of which 404 were cases who underwent 
primary shunt insertion and 24 were old  cases of shunt insertion who underwent 
shunt   revision.
• A total  of 120 cases with shunt  malfunction were taken for the study which 
included 96 cases who had one episode of shunt malfunction among the 404 
cases and also the 24 old cases who presented with shunt malfunction during the 
study period.
• 36 cases were infected after their primary shunt surgery resulting in an infection 
rate of 8.9%. Two cases had recurrence of infection. In 24 cases with multiple 
revisions, the infection rate was 20.8%.
• The underlying condition of the patient that necessitated shunt in children were 
mainly congenital malformations (54.4%), followed by preceding    meningitis 
(21.8%), CNS tumour (15.7%), idiopathic (6%), subarachnoid    haemorrhage 
(2%).  In  adults  CNS tumour (50%) were common followed by    preceding 
meningitis (28.3%) and idiopathic (21.7%).
• Most  infections  occurred  with  in  one  to  two  months  of  surgery.  63.9%  of 
infections occurred within one month, 86.1% in 2 months and 94.4% presented 
within 3 months.
• Young age,  less  than  six  months  of  age  was  a  main  risk  factor.  13 out  of  
41 cases were within 6 months of age.
• Infection  rates  were  higher  with  myelomeningocele  (21.4%),  preceding 
meningitis (20%), subarachnoid haemorrhage (20%) in children. In adults the 
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infection rates were comparatively less.
• Fever,  seizures,  altered  consciousness,  CSF  leak,  displaced  shunt  were  the 
symptoms most commonly associated with shunt infection. Headache, vomiting, 
abdominal signs and wound changes were less common symptoms.
• CSF pleocytosis, neutrophilia, low glucose level, high protein level were found 
in  increased  frequency  with  the  infected  group.   Using  Chi-square  test,  the 
values in infected group was found to be significantly different from the non 
infected group with P<0.05.
• Gram staining was positive in 86.4% of Gram-negative infections as compared 
to only 33.3% in case of Gram- positive infections.
• The correlation between Gram staining and CSF neutrophilia can be very helpful 
in choice of antibiotic for empirical therapy.
• The  commonest  organism  isolated  was Staphylococcus  epidermidis (32%) 
followed  by  staphylococcus  aureus  (18%),   Klebsiella  pneumonia  (12%), 
Escherichia  coli (10%), Pseudomonas  aeroginosa (10%),  Klebsiella  oxytoca 
(4%), Acinetobacter baumannii  (4%).  The remaining organisms isolated were 
Micrococcus  luteus,  Enterococcus  faecalis,  and  Citrobacter  diversus  all 
contributing  to  about  2%.  Morganella  morganii (2%)  was  isolated  in  mixed 
infection along with  E. coli. One Candida albicans was isolated in a recurrent 
infection.
• 62.5% episodes of infection were caused by slime producing  Staphylococcus 
epidermidis   
• Bacteremia was detected in 4.7% of infected cases and carried grave prognosis.
• Gram-positive  cocci  showed  100%  sensitivity  to  Vancomycin,  followed  by 
ofloxacin, gentamicin, cefotaxime, oxacillin, ampicillin where as Gram-negative 
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bacilli  showed  100%  sensitivity  to  imipenam  followed  by  cefaperazone-
sulbactam, amikacin, ceftazidime, ofloxacin and ampicillin.
• MRSA and MRSE strains accounted for about 22.2% and 25% of the isolates 
respectively.
• β-lactamase production was detected in 37.5% of the isolates in S. epidermidis  
and 33.3% of the isolates in S. aureus. ESBL producing strains were detected in 
Klebsiella  pneumoniae  (33.3%) Escherichia  coli  (40%),  Pseudomonas 
aeroginosa (20%).
• Amp C beta-lactamase was positive in one strain of Klebsiella pneumoniae.
• MIC break points of Benzyl  penicillin for penicillin resistant  staphylococcal 
species  were  between   8µg/ml  to  32  g/dl.  MIC  breakpoints  of  ceftazidime 
resistant Gram negative bacilli  were between 32 g/dl-128 g/dl.
• The source of infection were  mostly skin commensals mostly occurring possibly 
during  surgery.  Also  the  possibility  of  nosocomial  infections  should  not  be 
ignored.
• Antibiotic use with external ventricular drainage (EVD) followed subsequently 
by a new shunt placement was the most effective treatment.
• An empirical regimen of ampicillin-cloxacillin(500 mg IV BD) was found to be 
effective in about 60% of shunt infections
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CONCLUSION
 Ventriculoperitoneal  shunt  infection  is  a  cause  of  significant  morbidity  and 
mortality, causing shunt malfunction and chronic ill health.
 The overall infection rate associated with ventriculoperitoneal shunts was 8.9%.
 Majority of the infections occurred within one to two months of surgery.
 The most frequently isolated organism was Staphylococcus epidermidis.
 Young  age,  cause  of  hydrocephalus  as  myelomeningocele,  multiple  shunt 
revisions were the main risk factors for shunt infection. 
 CSF Gram staining and CSF neutrophil  count is of immense help in starting 
empirical antibiotic therapy.
 Early  identification  and  with  the  use  of  appropriate  antibiotics  both 
prophylactically  as  well  as   long  term   along  with  prompt  removal  of  and 
replacement of the drainage system will ensure a good outcome.
 Surveillance  of  MRSA  and  ESBLs  are  essential  to  implement  strict  control 
measures and antibiotic policies to combat bacterial drug resistance.
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PROFORMA
A STUDY ON VENTRICULOPERITONEAL 
SHUNT INFECTIONS
Name : No :
Age : Sex :
Address :
History of Presenting illness
H/o. Fever
H/o. Seizures
H/o. Disturbed consciousness
H/o. Hydrocephalus
H/o. Abdominal signs - fullness, pain, vomiting, poor appetite
H/o. Septic Shock
H/o. Incessant Cry
H/o. Shunt dysfunction
H/o. Underlying pathology like brain tumour, ICH, SCH, Craniotomy, 
Head injury
H/o. Use of antacid and H2 blocking agents
H/o. Previous shunt revision
Date of Shunt Procedure Done:
Duration between shunt insertion 
and shunt infection
O/E
General Examination
Consciousness
Pupils equally reacting to light
Anterior fontanelle
Head circumference
Heart rate
Sensory system
Motor system
Cranial nerve examination
Local examination
Erythema or induration along the shunt tract
Wound changes
Investigations
I. Biochemical analysis
CSF - Glucose, proteins and Pandy's test for globulin
II. CSF Cell count - Total count and differential count
III. Microbiological study
i) CSF or shunt tip
a) Direct Gram stain
b) Culture and sensitivity - aerobic, anaerobic and fungal
ii) Blood - Culture and sensitivity
iii) Skin surface swabs for endogenous source of infection - culture and 
sensitivity.
iv) Environmental samples for exogenous source of infection - culture 
and sensitivity.
 
Follow up of the patient:
i) History of relapse
ii) History of recurrence
iii) Outcome
